Macrolides
US6472371B1 · kind B1 · utility
11Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 23, 2000 |
| Grant date | Oct 29, 2002 |
| Priority date | — |
| Expiry date | May 23, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H17/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel erythromycin analogs and azalides, particularly ones with novel C-13 substituents, and to pharmaceutically acceptable salts thereof. The compounds of this invention are antibacterial agents that may be used to treat various bacterial and protozoa infections. The invention also relates to pharmaceutical compositions containing such compounds and to methods of treating bacterial protozoa infections by administering such compounds. The invention also relates to methods of preparing such compounds and to intermediates useful in such preparation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.